| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |